BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15968390)

  • 21. Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension.
    Helle F; Vågnes ØB; Iversen BM
    Am J Physiol Renal Physiol; 2006 Jul; 291(1):F140-7. PubMed ID: 16467128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic angiotensin II infusion modulates angiotensin II type I receptor expression in the subfornical organ and the rostral ventrolateral medulla in hypertensive rats.
    Nunes FC; Braga VA
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):440-5. PubMed ID: 21393361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats.
    Axelsson J; Rippe A; Oberg CM; Rippe B
    Am J Physiol Renal Physiol; 2012 Sep; 303(6):F790-9. PubMed ID: 22718887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
    Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
    Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
    Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
    Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
    J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of losartan and carvedilol on vasopressor responses to adrenergic agonists and angiotensin II in the systemic circulation of Sprague Dawley rats.
    Abdulla MH; Sattar MA; Abdullah NA; Khan MA; Anand Swarup KR; Johns EJ
    Auton Autacoid Pharmacol; 2011; 31(1-2):13-20. PubMed ID: 21166975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteinuric potentials of angiotensin II, [des-Asp1]-angiotensin II, and [des-Asp1, des-Arg2]-angiotensin II in rats.
    Terui J; Tamoto K; Sudo J
    Biol Pharm Bull; 1994 Nov; 17(11):1516-8. PubMed ID: 7703976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NADPH oxidase-dependent formation of reactive oxygen species contributes to angiotensin II-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells.
    Chang J; Jiang Z; Zhang H; Zhu H; Zhou SF; Yu X
    Int J Mol Med; 2011 Sep; 28(3):405-12. PubMed ID: 21537828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
    Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E
    Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture.
    Skurk T; Lee YM; Hauner H
    Hypertension; 2001 May; 37(5):1336-40. PubMed ID: 11358950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
    Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
    Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympatho-inhibitory properties of various AT1 receptor antagonists.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.
    Ridker PM; Gaboury CL; Conlin PR; Seely EW; Williams GH; Vaughan DE
    Circulation; 1993 Jun; 87(6):1969-73. PubMed ID: 8504511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB; Black MJ; Bertram JF; Bobik A
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.
    Stragier B; Sarre S; Vanderheyden P; Vauquelin G; Fournié-Zaluski MC; Ebinger G; Michotte Y
    J Neurochem; 2004 Sep; 90(5):1251-7. PubMed ID: 15312180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II pressor response in the L-NAME-induced hypertensive pithed rat: role of the AT1 receptor.
    Figueroa-Guillén ES; Castro-Moreno P; Rivera-Jardón FF; Gallardo-Ortiz IA; Ibarra-Barajas M; Godínez-Hernández D
    Proc West Pharmacol Soc; 2009; 52():54-6. PubMed ID: 22128423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The coronary endothelium behaves as a functional diffusion barrier for intravascular Angiotensin II.
    Rubio R; Torres-Tirado D; Castillo-Hernandez J; Chi-Ahumada E; Ramiro-Diaz J; Knabb M
    Vascul Pharmacol; 2013 Jan; 58(1-2):54-63. PubMed ID: 22925777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.